| These findings indicate that miR-320a suppresses the growth of colon cancer cells by directly targeting beta-catenin, suggesting its application in prognosis prediction and cancer treatment. | colorectal, |
| MiR-320a acts as a novel tumor suppressor gene by targeting BCR/ABL oncogene in chronic myeloid leukemia. | leukemia, |
| Direct regulation of LAMP1 by tumor-suppressive microRNA-320a in prostate cancer | prostate, |
| Data provided evidence that miR-320a-3p might work as a tumor suppressor in non-small cell lung cancer (NSCLC) both in vivo and in vitro. High expression of miR-320a-3p suppresses cell proliferation, migration and invasion through the down-regulation of ELF3 and therefore the inactivation of PI3K/Akt pathway in NSCLC cells. | lung, |
| Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a | osteosarcoma, |
| MicroRNA-320a acts as a tumor suppressor in endometrial carcinoma by targeting IGF-1R | endometrial, |
| The findings of the present study suggested that miR320a may function as a tumor suppressor in GC progression and potential therapeutic strategies for GC may be based on the miR320a/ADAM10 axis. | None |